e-learning
resources
Virtual 2020
Pre-Congress Content
New investigations of bronchiectasis and non-tuberculous mycobacteria
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchiectasis: prevalance of asthma diagnosis and asthma-associated factors
T. van der Veer (Rotterdam, Netherlands), M. Bakker (Rotterdam, Netherlands), L. Kamphuis (Rotterdam, Netherlands), A. Dubois (Rotterdam, Netherlands), R. Hoek (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Van Der Eerden (Rotterdam, Netherlands)
Source:
Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Session:
New investigations of bronchiectasis and non-tuberculous mycobacteria
Session type:
E-poster session
Number:
3329
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. van der Veer (Rotterdam, Netherlands), M. Bakker (Rotterdam, Netherlands), L. Kamphuis (Rotterdam, Netherlands), A. Dubois (Rotterdam, Netherlands), R. Hoek (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Van Der Eerden (Rotterdam, Netherlands). Bronchiectasis: prevalance of asthma diagnosis and asthma-associated factors. 3329
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Severe bronchial asthma: risk factors
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
The research of the bronchial asthma and risk factors of asthma prevalence in Yekaterinburg
Source: Eur Respir J 2007; 30: Suppl. 51, 147s
Year: 2007
Asthma in adults: association of asthma symptoms and age at asthma diagnosis
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020
Risk factors for severe asthma among adults with asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020
Recurrent exacerbation of asthma: Characteristics of the patients and risk factors
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Bronchiectasis and aspergillus-associated diseases in severe asthma
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Risk factors for severe bronchial asthma in young adults with childhood-onset asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Risk factors for frequent exacerbations in (ex)smoking and never-smoking adult-onset asthma patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Comorbidities in asthma: the role of obesity in children with asthma
Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents?
Year: 2020
Nasal symptoms and doctor-diagnosed chronic lung diseases
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Allergic rhinitis in children: prevalence and risk factors
Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children
Year: 2009
Role of eczema as a risk factor for childhood asthma
Source: Annual Congress 2009 - Epidemiology and risk factors of childhood asthma: what every clinician should know
Year: 2009
Risk factors for moderate exacerbations in childhood asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004
The prevalences of asthma and atopy in bronchiectasis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 322s
Year: 2006
Distinct features of chronic rhinosinusitis and risk factors for asthma
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
Atopy is a risk factor for COPD symptoms: Results from the EUROSCOP study
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation
Source: Eur Respir J 2006; 28: Suppl. 50, 449s
Year: 2006
Risk factors for severe exacerbations in asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002
Perennial allergy is a modifiable risk factor for exacerbations and respiratory infections in asthma patients
Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept